CAROLYN NARTNIK: Open Payments
NPI 1710630793 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 11 payments from 9 companies in 2025. Trend: 2023 $136 · 2024 $153 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $153 |
| Lilly USA, LLC | 2 | $49 |
| Novo Nordisk Inc | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Nalu Medical, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: FREESTYLE LIBRE 3, JARDIANCE, Ozempic, CAPLYTA, TRELEGY ELLIPTA, JOURNAVX, MOUNJARO, VOQUEZNA.
Industry payments across WA — which companies pay providers there.
